SEARCH

SEARCH BY CITATION

References

  • 1
    Lombardino JG, Love III JA. The role of the medicinal chemistry in drug discovery – then and now. Nat Rev Drug Discov. 2004; 3: 85362.
  • 2
  • 3
    Lundstrom K. The future of G protein-coupled receptors as targets in drug discovery. Idrugs. 2005; 8: 90913.
  • 4
    Helenius A, Simons K. Solubilization of membranes by detergents. Biochim Biophys Acta. 1975; 415: 2979.
  • 5
    Loll PJ. Membrane protein structural biology: the high throughput challenge. J Struct Biol. 2003; 142: 14453.
  • 6
    Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima F, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science. 2000; 289: 73945.
  • 7
    Blundell TL. Structure-based drug design. Nature. 1996: 384S: 236.
  • 8
    Campbell SF. Science, art and drug discovery: a personal perspective. Clin Sci. 2000; 99: 25560.
  • 9
    Blundell TL, Patel S. High-throughput X-ray crystal-lography for drug discovery. Curr Opin Pharmacol. 2004; 4: 4906.
  • 10
    Blundell TL, Sibanda BL, Montalvao RW, Brewerton S, Chelliah V, Worth CL, Harmer NJ, Davies O, Burke D. Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery. Philos Trans R Soc Lond B Biol Sci. 2006; 361: 41323.
  • 11
    Blundell TL, Jhoti H, Abell C. High throughput crystallography for lead discovery in drug design. Nat Rev Drug Discov. 2002; 1: 4554.
  • 12
    Nienaber VL, Richardson PL, Klighofer V, Bouska JJ, Giranda VL, Greer J. Discovering novel ligands for macromolecules using X-ray crystallography screening. Nat Biotechnol. 2000; 18: 11058.
  • 13
    Blundell TL, Abell C, Cleasby H, Hartshorn MJ, Tickle IJ, Parasini E, Jhoti H. High throughput X-ray crystallography for drug discovery. In: DFlower, editor. Drug design, cutting edge approaches. London : Royal Society Chemistry; 2002. p. 539.
  • 14
    Huth JR, Yu L, Collins I, Mack J, Mendoza R, Isaac B, Braddock DT, Muchmore SW, Comess KM, Fesik SW, Clore GM, Levens D, Hajduk PJ. NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter. J Med Chem. 2004; 47: 48517.
  • 15
    Hardy LW, Malikayil A. The impact of structure-guided drug design on clinical agents. Curr Drug Discov. 2003; 3: 1520.
  • 16
    Stoll V, Qin W, Stewart KD, Jakob C, Park C, Walter K, Simmer RL, Helfrich R, Bussiere D, Kao J, Kempf D, Sham HL, Norbeck DW. X-ray crystallo-graphic structure of ABT-378 (lopinavir) bound to HIV-1 protease. Bioorg Med Chem. 2002; 10: 28036.
  • 17
    Varghese JN. Development of neuroaminidase inhibitors as anti-influenza virus drugs. Drug Dev Res. 1999; 46: 17696.
  • 18
    Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, Kuriyan J. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science. 2000; 289: 193842.
  • 19
    Kumar CC, Madison V. AKT crystal structure and AKT-specific inhibitors. Oncogene. 2005; 24: 7493501.
  • 20
    Wallis RM, Corbin JD, Francis SH, Ellis P. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol. 1999; 83: 3C12C.
  • 21
    Katzen F, Chang G, Kudlicki W. The past, present and future of cell-free protein synthesis. Trends Biotechnol. 2005; 23: 1506.
  • 22
    Yokoyama S. Protein expression systems for structural genomics and proteomics. Curr Opin Chem Biol. 2003; 7: 3943.
  • 23
    Klammt C, Lšhr F, SchŠfer B, Haase W, Dštsch V, Rterjahns H, Glaubitz C, Bernhard F. High level cell-free expression and specific labeling of integral membrane proteins. Eur J Biochem. 2004; 271: 56880.
  • 24
    Ishihara G, Goto M, Saeki M, Ito K, Hori T, Kigawa T, Shirouzu M, Yokoyama S. Expression of G protein coupled receptors in a cell-free translational system using detergents and thioredoxinfusion vectors. Prot Expr Purif. 2005; 41: 2737.
  • 25
    Pornillos O, Chen YJ, Chen AP, Chang G. X-ray structure of the EmrE multidrug transporter in complex with a substrate. Science. 2005; 310: 19503.
  • 26
    Miroux B, Walker JE. Over-production of proteins in Escherichia coli: Mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol. 1996; 260: 28998.
  • 27
    Clough J, Saidijam M, Bettaney K, Szakonyi G, Patching S, Meuller J, Suzuki S, Shibayama K, Bacon M, Barksby E, Groves M, Herbert R, Phillip-Jones M, Ward A, Gunn-More F, O’Reilly J, Rutherford N, Bill R, Henderson P. Prokaryotic membrane transport proteins: amplified expression and purification. In: K.Lundstrom, editor. Structural genomics on membrane proteins. Boca Raton : CRC Press; 2006. p. 2142.
  • 28
    Tucker J, Grisshammer R. Purification of a rat neurotensin receptor expressed in Escherichia coli. Biochem J. 1996; 317: 8919.
  • 29
    Weiss HM, Grisshammer R. Purification and characterization of the human adenosine A(2a) receptor functionally expressed in Escherichia coli. Eur J Biochem. 2002; 269: 8292.
  • 30
    Grisshammer R. Understanding recombinant expression of membrane proteins. Curr Opin Biotechnol. 2006; 17: 33740.
  • 31
    Kiefer H. In vitro folding of alpha-helical membrane proteins. Biochim Biophys Acta. 2003; 1610: 5762.
  • 32
    Lopez de Maturana R, Willshaw A, Kuntzsch A, Rudolph R, Donnelly D. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds expending peptides with much higher affinity than GLP-1. J Biol Chem. 2003; 278: 10195200.
  • 33
    Baneres JL, Martin A, Hullot P, Girard JP, Rossi JC, Parello J. Structure-based analysis of GPCR function: conformational adaptation of both agonist and receptor upon leukotriene B4 binding to recombinant BLT1. J Mol Biol. 2003; 329: 80114.
  • 34
    Baneres JL, Mesnier D, Martin A, Joubert L, Dumuis A, Bockaert J. Molecular characterization of a purified 5-HT4 receptor: a structural basis for drug efficacy. J Biol Chem. 2005; 280: 2025360.
  • 35
    Kunji ER, Slotboom DJ, Poolman B. Lactococcus lactis as host for overproduction of functional membrane proteins. Biochim Biophys Acta. 2003; 1610: 97108.
  • 36
    De Ruyter PG, Kuipers OP, De Vos WM. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol. 1996; 62: 36627.
  • 37
    Monne M, Chan KW, Slotboom DJ, Kunji ER. Functional expression of eukaryotic membrane proteins in Lactococcus lactis. Protein Sci. 2005; 14: 304856.
  • 38
    Palva I, Lehtovaara P, Kaariainen L, Sibakov M, Cantell K, Schein CH, Kashiwagi K, Weissmann C. Secretion of interferon by Bacillus subtilis. Gene. 1983; 22: 22935.
  • 39
    Akiba S, Hayashi Y, Hakamada Y, Endo K, Ara K, Kawai S, Saitoh E. Extracellular production of human cystatin S and cystatin SA by Bacillus subtilis. Protein Expr Purif. 2006; 49: 20310.
  • 40
    Luecke H, Schobert B, Cartailler JP, Richter HT, Rosengarth A, Needleman R, Lanyi JK. Coupling photoisomerization of retinal to directional transport in bacteriorhodopsin. J Mol Biol. 2000; 300: 123755.
  • 41
    Turner GJ, Reusch R, Winter-Vann AM, Martinez L, Betlach MC. Heterologous gene expression in a membrane-protein-specific system. Prot Expr Purif. 1999; 17: 31223.
  • 42
    Bartus CL, Jaakola VP, Reusch R, Valentine HH, Heikinheimo P, Levay A, Potter LT, Heimo H, Goldman A, Turner GJ. Downstream coding region determinants of bacterio-opsin, muscarinic acetyl-choline receptor and adrenergic receptor expression in Halobacterium salinarum. Biochim Biophys Acta. 2003; 1610: 10923.
  • 43
    Melmer G. Biopharmaceuticals and the industrial environment, discovery. In: G.Gellissen, editor. Production of recombinant proteins – novel microbial and eukaryotic expression systems. Weinheim : Wiley-VCH; 2005. p. 36183.
  • 44
    Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature. 1982; 298: 34750.
  • 45
    Cabezon T, De Wilde M, Herion P, Loriau R, Bollen A. Expression of human alpha 1-antitrypsin cDNA in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 1984; 81: 65948.
  • 46
    Hinnen A, Meyhack B, Tsapis R. High expression and secretion of foreign proteins in yeast. In: M.Korhola, E.Väisänen, editors. Gene expression in yeast: foundation for biotechnical and industrial fermentation research. Helsinki : Kauppakirjapaino; 1983. p. 15766.
  • 47
    Sakai A, Shimizu Y, Hishinuma F. Isolation and characterization of mutants which show an oversecretion phenotype in Saccharomyces cerevisiae. Genetics. 1988; 119: 499506.
  • 48
    David NE, Gee M, Andersen B, Naider F, Thorner J, Stevens RC. Expression and purification of the Saccharomyces cerevisiae alpha-factor receptor (Ste2p), a 7-transmembrane-segment G protein-coupled receptor. J Biol Chem. 1997; 272: 1555361.
  • 49
    Andersen B, Stevens RC. The human D1A dopamine receptor: heterologous expression in Saccharomyces cerevisiae and purification of the functional receptor. Prot Expr Purif. 1998; 13: 1119.
  • 50
    Sizmann D, Kuusinen H, Keranen S, Lomasney J, Caron MG, Lefkowitz RJ, Keinanen K. Production of adrenergic receptors in yeast. Recept Channels. 1996; 4: 197203.
  • 51
    Jidenko M, Nielsen RC, Sorensen TL, Moller JV, Le Maire M, Nissen P, Jaxel C. Crystallization of a mammalian membrane protein overexpressed in Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 2005; 102: 1168791.
  • 52
    Broker M, Bauml, O. New expression vectors for the fission yeast Schizosaccharomyces pombe. FEBS Lett. 1989; 248: 10510.
  • 53
    Sander P, Grunewald S, Maul G, Reilander H, Michel H. Constitutive expression of the human D2S-dopamine receptor in the unicellular yeast Saccharomyces cerevisiae. Biochim Biophys Acta. 1994; 1193: 25562.
  • 54
    Presland J, Strange PG. Pharmacological characterization of the D2 dopamine receptor expressed in the yeast Schizosaccharomyces pombe. Biochem Pharmacol. 1998; 56: 57782.
  • 55
    Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM. Heterologous protein production using the Pichia pastoris expression system. Yeast. 2005; 22: 24970.
  • 56
    Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev. 2000; 24: 4566.
  • 57
    Thomas L, Crawford, DL. Cloning of clustered Streptomyces viridosporus T7A lignocellulose catabolism genes encoding peroxidase and endoglucanase and their extracellular expression in Pichia pastoris. Can J Microbiol. 1998; 44: 36472.
  • 58
    Weiss HM, Haase W, Michel H, Reilander H. Expression of functional mouse 5-HT5A serotonin receptor in the methylotrophic yeast Pichia pastoris: pharmacological characterization and localization. FEBS Lett. 1995; 377: 4516.
  • 59
    Reinhart C, Kettler C. Expression of membrane proteins in yeast. In: K.Lundstrom, editor. Structural genomics on membrane proteins. Boca Raton : CRC Press; 2006. p. 11552.
  • 60
    Lundstrom K, Wagner R, Reinhart C, Desmyter A, Cherouati N, Magnin T, Zeder-Lutz G, Courtot M, Prual C, Andr N, Hassaine G, Michel H, Cambillau C, Pattus F. Structural genomics on membrane proteins – comparison of more than 100 GPCRs in 3 expression systems. J Struct Funct Genomics. 2006; 7: 7791.
  • 61
    Tornroth-Horsefield S, Wang Y, Hedfalk K, Johanson U, Karlsson M, Tajkhorshid E, Neutze R, Kjellbom P. Structural mechanism of plant aquaporin gating. Nature. 2006; 439: 68894.
  • 62
    Parcej DN, Eckhardt-Strelau L. Structural characterisation of neuronal voltage-sensitive K+ channels heterologously expressed in Pichia pastoris. J Mol Biol. 2003; 333: 10316.
  • 63
    Long SB, Campbell EB, MacKinnon R. Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science. 2005; 309: 897903.
  • 64
    Luque T, O’Reilly DR. Generation of baculovirusex-pression vectors. Mol Biotechnol. 1999; 13: 15363.
  • 65
    Klaassen CHW, De Grip WJ. Baculovirus expression system for expression and characterization of functional recombinant visual pigments. Meth Enzymol. 2000; 315: 1229.
  • 66
    Bosman GJ, De Grip WJ. Expression of functional membrane proteins in the baculovirus-insect cell system: challenges and developments. In: K.Lundstrom, editor. Structural genomics on membrane proteins. Boca Raton : CRC Press; 2006. p. 15367.
  • 67
    Akermoun M, Koglin M, Zvalova-Iooss D, Folschweiller N, Dowell SJ, Gearing KL. Characterization of 16 human G protein-coupled receptors expressed in baculovirus-infected insect cells. Prot Expr Purif. 2005; 44: 6574.
  • 68
    Benting J, Lecat S, Zacchetti D, Simons K. Protein expression in Drosophila Schneider cells. Anal Biochem. 2000; 278: 5968.
  • 69
    Johanson K, Appelbaum E, Doyle M, Hensley P, Zhao B, Abdel-Meguid SS, Young P, Cook R, Carr S, Matico R, Donna Cusimano, Edward Dul, Monica Angelichio, Ian Brooks, Evon Winborne, Peter McDonnell, Thomas Morton, Donald Bennett, Theodore Sokoloski, Dean McNulty, Martin Rosenberg, Irwin Chaiken. Binding interactions of human interleukin 5 with its receptor alpha subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins. J Biol Chem. 1995; 270: 945971.
  • 70
    Perret BG, Wagner R, Lecat S, Brillet K, Rabut G, Pattus F. Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: a potential expression system for large-scale production of G-protein coupled receptors. Prot Expr Purif. 2003; 31: 12332.
  • 71
    Saito H, Kubota M, Roberts RW, Chi Q, Matsunami H. RTP family members induce functional expression of mammalian odorant receptors. Cell. 2004; 119: 67991.
  • 72
    Von Dannecker LE, Mercadante AF, Malnic B. Ric-8B promotes functional expression of odorant receptors. Proc Natl Acad Sci USA. 2006; 103: 93104.
  • 73
    Makrides SC. Vectors for gene expression in mammalian cells. In: S.C.Makrides, editor. Gene transfer and expression in mammalian cells. Amsterdam : Elsevier Science B.V. 2003. p. 926.
  • 74
    Walter CA, Humphrey RM, Adair GM, Nairn RS. Characterization of Chinese hamster ovary cells stably transformed by a plasmid with an inducible APRT gene. Plasmid. 1991; 25: 20816.
  • 75
    Chelikani P, Reeves PJ, Rajbhandary UL, Khorana HG. The synthesis and high-level expression of a beta2-adrenergic receptor gene in a tetracycline-inducible stable mammalian cell line. Protein Sci. 2006; 15: 143340.
  • 76
    Prather PL, McGinn TM, Claude PA, Liu-Chen LY, Loh HH, Law PY. Properties of a kappa-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual G alpha sub-unit and is similar to that of other opioid receptors. Brain Res Mol Brain Res. 1995; 29: 33646.
  • 77
    Reeves PJ, Kim JM, Khorana HG. Structure and function in rhodopsin: a tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants. Proc Natl Acad Sci USA. 2002; 99: 134138.
  • 78
    Lundstrom K. Expression of membrane proteins in mammalian cells. In: K.Lundstrom, editor. Structural genomics on membrane proteins. Boca Raton : CRC Press; 2006. p. 16978.
  • 79
    Jacobs SC, Stephenson JR, Wilkinson GW. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J Virol. 1992; 66: 208695.
  • 80
    Zhen Z, Bradel-Tretheway BG, Drewhurst S, Bidlack JM. Transient overexpression of kappa and mu opioid receptors using recombinant adenovirus vectors. J Neurosci Methods. 2004; 136: 1339.
  • 81
    Drazner MH, Peppel KC, Dyer S, Grant AO, Koch WJ, Lefkowitz RJ. Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes. J Clin Invest. 1997; 99: 28896.
  • 82
    Niles EG, Studier FW, Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA. 1986; 83: 81226.
  • 83
    Carroll MW, Wilkinson GWG, Lundstrom K. Mammalian expression systems and vaccination. In: RingC.J.A., BlairE.D., editors. Genetically engineered viruses. Oxford : BIOS Scientific Publishers Ltd; 2001. p. 10757.
  • 84
    Walker P, Munoz M, Combe MC, Grouzmann E, Herzog H, Selbie L, Shine J, Brunner HR, Waeber B, Wittek R. High level expression of human neuropeptide Y receptors in mammalian cells infected with a recombinant vaccinia virus. Mol Cell Endocrinol. 1993; 91: 10712.
  • 85
    Bouvier M, Chidiac P, Hebert TE, Loisel TP, Moffett S, Mouillac B. Dynamic palmitoylation of G-protein-coupled receptors in eukaryotic cells. Methods Enzymol. 1995; 250: 30014.
  • 86
    Gasmi M, Wong-Staal F. Virus-based vectors for gene expression in mammalian cells: lentiviruses. In: MakridesS.C., editor. Gene transfer in mammalian cells. Amsterdam : Elsevier Science B.V.; 2003. p. 25164.
  • 87
    Yang M, Wang XG, Stout JT, Chen P, Hjelmeland LM, Appukuttan B, Fong HK. Expression of a recombinant human RGR opsin in Lentivirus-transduced cultured cells. Mol Vis. 2000; 6: 23742.
  • 88
    Liljestrom P, Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y). 1991; 9: 135661.
  • 89
    Lundstrom K. Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim Biophys Acta. 2003; 1610: 906.
  • 90
    Hassaine G, Wagner R, Kempf J, Cherouati N, Hassaine N, Prual C, Andr N, Reinhart C, Pattus F, Lundstrom K. Semliki Forest Virus vectors for overexpression of 101 G Protein-coupled receptors in mammalian host cells. Prot Purif Expr. 2006; 45: 34351.
  • 91
    Lundstrom K, Michel A, Blasey H, Bernard AR, Hovius R, Vogel H, Surprenant A. Expression of ligand-gated ion channels with the Semliki Forest virus expression system. J Recept Signal Transduct Res. 1997; 17: 11526.
  • 92
    Lundstrom K. Semliki Forest virus vectors: versatile tools for efficient large-scale expression of membrane receptors. In: KühneS.R., De GrootH.J.M., editors. Perspectives on solid state NMR in biology. Netherlands : Kluwer Academic Publishers; 2001. p. 1319.
  • 93
    Lee AG. How lipids interact with an intrinsic membrane protein: the case of the calcium pump. Biochim Biophys Acta. 1998; 1376: 38190.
  • 94
    Keyes MH, Gray DN, Kreh KE, Sanders CR. Solubilizing detergents for membrane proteins. In: S.Iwata, editor. Methods and results in crystallisation of membrane proteins. San Diego : IUL; 2003. p. 1738.
  • 95
    Byrne B, Jormakka M. Solubilization and purification of membrane proteins, In: LundstromK., editor. Structural genomics on membrane proteins. Boca Raton : CRC Press; 2006. p. 17998.
  • 96
    Abola E, Kuhn P, Earnest T, Stevens RC. Automation of X-ray crystallography. Nat Struct Biol. 2000; 7: 9737.
  • 97
    Tickle I, Shariff A, Vinkovic M, Yon J, Jhoti H. Highthroughput protein crystallography and drug discovery. Chem Soc Rev. 2004; 33: 55865.
  • 98
    Shuker SB, Hajduk PJ, Meadows RP, Fesik SW. Discovering high-affinity ligands for proteins: SAR by NMR. Science. 1996; 274: 15314.
  • 99
    Moore JM. NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery. Biopolymers. 1999; 51: 22143.
  • 100
    Powers R. Applications of NMR to structure-based drug design in structural genomics. J Struct Funct Genomics. 2002; 2: 11323.
  • 101
    Xie X-Q. Membrane protein NMR. In: LundstromK., editor. Structural genomics on membrane proteins. Boca Raton : CRC Press; 2006. p. 21159.
  • 102
    Engel A. Electron microscopy and atomic force microscopy of reconstituted membrane proteins. In: LundstromK., editor. Structural genomics on membrane proteins. Boca Raton : CRC Press; 2006. p. 30020.
  • 103
    Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol. 1990; 213: 899929.
  • 104
    Murata K, Mitsuoka K, Hirai T, Walz T, Agre P, Heymann JB, Engel A, Fujiyoshi Y. Structural determinants of water permeation through aquaporin-1. Nature. 2000; 407: 599605.
  • 105
    Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, Palczewski K. Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature. 2003; 421: 1278.
  • 106
    Goulding CW, Perry LJ, Anderson D, Sawaya MR, Cascio D, Apostol MI, Chan S, Parseghian A, Wang SS, Wu Y, Cassano V, Gill HS, Eisenberg D. Structural genomics of Mycobacterium tuberculosis: a preliminary report of progress at UCLA. Biophys Chem. 2003; 105: 36170.
  • 107
    Essen LO. Structural genomics of “non-standard” proteins: a chance for membrane proteins? Gene Funct Dis. 2002; 3: 3948.
  • 108
    Canaves JM, Page R, Wilson IA, Stevens RC. Protein biophysical properties that correlate with crystallization success in Thermotoga maritima: maximum clustering strategy for structural genomics. J Mol Biol. 2004; 344: 97791.
  • 109
    Yokoyama S, Hirota H, Kigawa T, Yabuki T, Shirouzu M, Terada T, Ito Y, Matsuo Y, Kuroda Y, Nishimura Y, Kyogoku Y, Miki K, Masui R, Kuramitsu S. Structural genomics projects in Japan. Nat Struct Biol. 2000; 7: Suppl. 9435.
  • 110
    Wang BC, Adams MW, Dailey H, Delucas L, Luo M, Rose J, Bunzel R, Dailey T, Habel J, Horanyi P, Jenney FE Jr, Kataeva I, Lee HS, Li S, Li T, Lin D, Liu ZJ, Luan CH, Mayer M, Nagy L, Newton MG, Ng J, Poole FL 2nd, Shah A, Shah C, Sugar FJ, Xu H. Protein production and crystallization at SECSG—an overview. J Struct Funct Genomics. 2005; 6: 23343.
  • 111
  • 112
    Andre N, Cherouati N, Prual C, Steffan T, Zeder-Lutz G, Magnin T, Pattus F, Michel H, Wagner R, Reinhart C. Enhancing functional production of G protein-coupled receptors in Pichia pastoris to levels required for structural studies via a single expression screen. Protein Sci. 2006; 15: 111526.